Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral Paralysis (CP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01929434|
Recruitment Status : Completed
First Posted : August 28, 2013
Last Update Posted : December 27, 2017
Cerebral palsy (CP) is described as a group of permanent disorders affecting motor development and posture, resulting in activity limitation attributed to nonprogressive disturbances of the fetal or infant brain. The prevalence of cerebral palsy has increased among the children with low birth-weight, jaundice, respiratory distress and intrauterine infection and so on. The incidence of cerebral palsy is increasing gradually with increased neonatal survival rate. Although there are many kinds of functional therapy programs especially the rehabilitation treatment for cerebral palsy, their effects are limited. Increasing cerebral palsy patients become a heavy burden to the family and society. Stem cell based therapy, a new prospective therapy for central nervous system disorders, has the potential to repair the damaged brain tissue in patients with cerebral palsy.
In this study, 300 patients with cerebral palsy will be divided into three groups and the investigators will use mesenchymal stem cells derived from umbilical cord to treat 100 CP patients of them randomly. We will also follow up the other 100 patients who only receive rehabilitation treatment and another 100 patients who accept neither stem cell therapy nor rehabilitation treatment. On this basis, as the investigators we can compare the efficacy of cell therapy and rehabilitation treatments for cerebral palsy patients.
Multiple sources of assessment were used to ascertain and classify all cases of cerebral palsy. Particularly the Gross Motor Function Measure (GMFM) as an important valid and reliable outcome measure, has made it possible to evaluate the severity of movement disability，change over time and the effects of clinical interventions. It also will be the primary outcome measure in follow-up analysis of this study.
|Condition or disease||Intervention/treatment||Phase|
|Cerebral Palsy||Other: rehabilitation Biological: stem cell injection||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||300 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Children With Cerebral Paralysis|
|Study Start Date :||October 2013|
|Actual Primary Completion Date :||December 2015|
|Actual Study Completion Date :||December 2016|
Active Comparator: rehabilitation
Patients in the group accept rehabilitation for three weeks in hospital and other eleven months in their home under the guidance of physical therapist.
Patients only receive rehabilitation of physical therapy and occupational therapy.
Other Name: phsical exercise rehabilitation
No Intervention: control
Patients receive no professional treatment in hospital or rehabilitation centre.
Experimental: stem cell injection
Patients in the group accept cell therapy including four times stem cells transplant via intrathecal injection.
Biological: stem cell injection
Mesenchymal stem cells derived from umbilical cord are transplanted directly into subarachnoid by Lumbar puncture.
- Gross Motor Function Measure Score [ Time Frame: Change from baseline at 12 monthes after enrollment or transplantation ]Gross Motor Function Measure-88 and Gross Motor Function Measure-66
- Routine Blood Test and Biochemical Test [ Time Frame: Change from baseline at 12 monthes after enrollment or transplantation ]
- red blood cell
- white blood cell
- platelet count
- glutamic pyruvic transaminase
- glutamic oxaloacetic transaminase
- Magnetic resonance imaging （MRI） [ Time Frame: Change from baseline at 12 monthes after enrollment or transplantation ]The MRI repots would describe brain tissue especially white matter and malacia.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01929434
|General Hospital of Chinese People's Armed Police Forces|
|Beijing, Beijing, China, 100050|
|Study Director:||Yihua An, Doctor||the General Hospital of Chinese People's Armed Police Forces|